April 2021

Inotiv Completes $51.7M Public Offering

Inotiv, Inc. (Nasdaq: NOTV), a contract research organization specializing in nonclinical and analytical drug discovery and development services, completed an underwritten public offering of $51.7 million of its common shares, including the full exercise by the underwriter of its option to purchase additional shares to cover over-allotments, on April 23, 2021. Colliers Securities LLC acted as Bookrunner and Sole Underwriter. Faegre Drinker represented Colliers Securities in the offering.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.